Coronary Model Shows Limits in Cath-Referred Patients
-
By
-
Andrea Surnit
-
June 22, 2026
-
5 min
By
Andrea Surnit
June 22, 2026
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026
The oral compound increased energy expenditure, reduced fat mass, and improved metabolic measures in male mouse models.
August 27, 2026
Nearly 1 in 3 participants discontinued the yearlong dietary program because of diet-related challenges, despite a 61% completion rate.
October 30, 2026